Immunotherapeutic interventions of Triple Negative Breast Cancer

Immunotherapeutic interventions of Triple Negative Breast Cancer

Abstract Triple Negative Breast Cancer (TNBC) is a highly heterogeneous subtype of breast cancer that lacks the expression of oestrogen receptors, progesterone receptors and human epidermal growth factor receptor 2. Although TNBC is sensitive to chemotherapy, the overall outcomes of TNBC are worse t...

Full description

Bibliographic Details
Main Authors: Zehuan Li, Yiran Qiu, Weiqi Lu, Ying Jiang, Jin Wang
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Journal of Translational Medicine
Subjects:
Triple Negative Breast Cancer
Immunotherapy
Chemotherapy
Antibody therapies
Exosome
Online Access:http://link.springer.com/article/10.1186/s12967-018-1514-7

Internet

http://link.springer.com/article/10.1186/s12967-018-1514-7

Similar Items